{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:50:56Z","timestamp":1791546656509,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jconrel.2019.03.029","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T02:59:31Z","timestamp":1553914771000},"page":"126-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension"],"prefix":"10.1016","volume":"302","author":[{"given":"Hend I.","family":"Shahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5172-789X","authenticated-orcid":false,"given":"Bhavani Prasad","family":"Vinjamuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza A.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab N.","family":"Shamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan M.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein O.","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Ghorab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahavir Bhupal","family":"Chougule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7221-6829","authenticated-orcid":false,"given":"Lipika","family":"Chablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.03.029_bb0005","series-title":"A Guide to Aerosol Delivery Devices for Respiratory Therapist\u20133rd","author":"Gardenhire","year":"2017"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0010","series-title":"Breathing in America: Diseases, Progress, and Hope","first-page":"175","article-title":"Chapter 17. Pulmonary hypertension","author":"Newman","year":"2010"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/pr.111.005587","article-title":"The pharmacological treatment of pulmonary arterial hypertension","volume":"64","author":"Frumkin","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2017.02.003","article-title":"Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH)","volume":"250","author":"Rashid","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3109\/10837450.2015.1086369","article-title":"Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics","volume":"21","author":"Ghasemian","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0030","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11095-011-0409-6","article-title":"PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-\u03b2-cyclodextrin (PGE1-HP\u03b2CD) complex for the treatment of pulmonary arterial hypertension (PAH)","volume":"28","author":"Gupta","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0035","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1378\/chest.15-0300","article-title":"Five-year outcomes of patients enrolled in the REVEAL registry","volume":"148","author":"Farber","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0040","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1542\/peds.2005-0523","article-title":"Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study","volume":"117","author":"Baquero","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/vhrm.2006.2.4.411","article-title":"Sildenafil in the treatment of pulmonary hypertension","volume":"2","author":"Barnett","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0050","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1450","article-title":"Pulmonary hypertension therapy and a systematic review of efficacy and safety of PDE-5 inhibitors","volume":"139","author":"Unegbu","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0735-1097(03)00555-2","article-title":"Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension","volume":"42","author":"Ghofrani","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0060","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/adc.88.9.827","article-title":"Sildenafil as a treatment for pulmonary hypertension","volume":"88","author":"Carroll","year":"2003","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.addr.2014.04.005","article-title":"Dry powders for oral inhalation free of lactose carrier particles","volume":"75","author":"Healy","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0075","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.biomaterials.2008.12.044","article-title":"Development of highly porous large PLGA microparticles for pulmonary drug delivery","volume":"30","author":"Yang","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0080","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.4155\/tde.13.90","article-title":"Hydrogels for controlled pulmonary delivery","volume":"4","author":"Du","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/17425247.4.3.297","article-title":"Design of fine particles for pulmonary drug delivery","volume":"4","author":"Weers","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11095-006-9174-3","article-title":"Particle engineering for pulmonary drug delivery","volume":"24","author":"Chow","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijpharm.2013.04.011","article-title":"Development of controlled release inhalable polymeric microspheres for treatment of pulmonary hypertension","volume":"450","author":"Saigal","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0100","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1208\/s12249-016-0633-9","article-title":"Formulation and characterization of polysaccharide microparticles for pulmonary delivery of sodium cromoglycate","volume":"18","author":"Gallo","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0105","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1248\/yakushi.131.1813","article-title":"Formulation optimization and characterization of spray dried microparticles for inhalation delivery of doxycycline hyclate","volume":"131","author":"Mishra","year":"2011","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.powtec.2014.02.033","article-title":"Influence of excipients on spray-dried powders for inhalation","volume":"256","author":"Xu","year":"2014","journal-title":"Powder Technol."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0115","first-page":"32","article-title":"Effects of hyaluronic acid on macrophage phagocytosis and active oxygen release","volume":"38","author":"Suzuki","year":"1993","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2016.01.066","article-title":"Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate","volume":"501","author":"Simon","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.powtec.2012.02.047","article-title":"Improvement of the dispersibility of spray-dried budesonide powders using leucine in an ethanol\u2013water cosolvent system","volume":"236","author":"Boraey","year":"2013","journal-title":"Powder Technol."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0130","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1208\/s12249-016-0668-y","article-title":"Inhalable ipratropium bromide particle engineering with multicriteria optimization","volume":"18","author":"Vinjamuri","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14227\/DT170210P6","article-title":"Optimization of an in vitro dissolution test method for inhalation formulations","volume":"17","author":"Son","year":"2010","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1208\/s12249-009-9213-6","article-title":"Intranasal microemulsion of sildenafil citrate: in vitro evaluation and in vivo pharmacokinetic study in rabbits","volume":"10","author":"Elshafeey","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0145","series-title":"Lung Surfactants","first-page":"132","article-title":"Discovery of endogenous lung surfactant and overview of its metabolism and actions","author":"Notter","year":"2000"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0150","series-title":"Treatise on Pulmonary Toxicology: Comparative Biology of the Normal Lung","author":"Parent","year":"1992"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0155","series-title":"<616> Bulk Density and Tapped Density of Powders","first-page":"6360","author":"USP","year":"2017"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.carbpol.2017.05.020","article-title":"Inhaled hyaluronic acid microparticles extended pulmonary retention and suppressed systemic exposure of a short-acting bronchodilator","volume":"172","author":"Li","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0165","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tube.2009.07.001","article-title":"Dry-powder pulmonary insufflation in the mouse for application to vaccine or drug studies","volume":"89","author":"Morello","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0170","unstructured":"Extreme vertices designs\/constrained mixture designs: NIST\/SEMATECH e-Handbook of Statistical Methods, https:\/\/www.itl.nist.gov\/div898\/handbook\/pri\/section5\/pri554.htm, 2013."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0175","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ejpb.2008.07.015","article-title":"Quality by design \u2013 spray drying of insulin intended for inhalation","volume":"70","author":"Maltesen","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0180","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2009"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0185","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1248\/cpb.42.1651","article-title":"Shear-rate dependence of the intrinsic viscosity of sodium hyaluronate in 0.2 M sodium chloride solution","volume":"42","author":"Yanaki","year":"1994","journal-title":"Chem. Pharm. Bull. (Tokyo)."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0190","series-title":"Particle Size Measurements: Fundamentals, Practice, Quality","author":"Merkus","year":"2009"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40005-013-0072-5","article-title":"Drug release testing methods of polymeric particulate drug formulations","volume":"43","author":"Amatya","year":"2013","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0200","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/jps.2600721021","article-title":"Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air","volume":"72","author":"Korsmeyer","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0205","series-title":"Analysis of Fickian and Non-Fickian Drug Release from Polymers","author":"Peppas","year":"1985"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0210","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1172\/JCI0215218","article-title":"Antimicrobial polypeptides in host defense of the respiratory tract","volume":"109","author":"Ganz","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2005.09.004","article-title":"The influence of formulation components on the aerosolisation properties of spray-dried powders","volume":"110","author":"Rabbani","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/mp200351y","article-title":"Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles","volume":"9","author":"El-Sherbiny","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0225","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s10973-012-2292-8","article-title":"Compatibility of sildenafil citrate and pharmaceutical excipients by thermal analysis and LC\u2013UV","volume":"111","author":"J\u00falio","year":"2013","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0230","series-title":"Analytical Profiles of Drug Substances and Excipients","author":"Brittain","year":"1994"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0235","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijpharm.2014.03.001","article-title":"Preparation of sildenafil citrate microcapsules and in vitro\/in vivo evaluation of taste masking efficiency","volume":"466","author":"Yi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0240","first-page":"513","article-title":"The effects of surface morphology on the aerosol performance of spray-dried particles within HFA 134a based metered dose formulations","volume":"10","author":"Yang","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0245","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejpb.2012.10.015","article-title":"The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules","volume":"83","author":"Sou","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10837459709031441","article-title":"The effect of operating and formulation variables on the morphology of spray-dried protein particles","volume":"2","author":"Maa","year":"1997","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0255","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0260","series-title":"Generalized Simplified Approaches for Mass Median Aerodynamic Determination, Pharmacopeial Forum","first-page":"812","volume":"vol. 36","author":"Christopher","year":"2010"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0265","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/jps.22003","article-title":"Swellable microparticles as carriers for sustained pulmonary drug delivery","volume":"99","author":"El-Sherbiny","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0270","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4155\/tde.13.64","article-title":"Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles","volume":"4","author":"Nokhodchi","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0275","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/toxsci\/70.2.212","article-title":"Mutagenicity and in vivo toxicity of combined particulate and semivolatile organic fractions of gasoline and diesel engine emissions","volume":"70","author":"Seagrave","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0280","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.etp.2005.05.011","article-title":"In vitro versus in vivo exposure to combustion emissions","volume":"57 (","author":"Seagrave","year":"2005","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/toxsci\/kfm018","article-title":"Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles","volume":"97","author":"Sayes","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0290","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejps.2010.02.007","article-title":"The use of sodium carboxymethylcellulose in the preparation of spray-dried proteins for pulmonary drug delivery","volume":"40","author":"Li","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0295","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/acs.molpharmaceut.5b00794","article-title":"A new class of safe oligosaccharide polymer therapy to modify the mucus barrier of chronic respiratory disease","volume":"13","author":"Pritchard","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0300","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2165\/00003495-199957060-00015","article-title":"Sildenafil","volume":"57","author":"Langtry","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0305","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/bja\/aeg117","article-title":"Drug handling by the lungs","volume":"91","author":"Boer","year":"2003","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jconrel.2019.03.029_bb0310","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/004982599238687","article-title":"Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man","volume":"29","author":"Walker","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jconrel.2019.03.029_bb0315","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nano.2015.08.009","article-title":"Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension","volume":"12","author":"Beck-Broichsitter","year":"2016","journal-title":"Nanomedicine"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919301890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919301890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:39:45Z","timestamp":1759160385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919301890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":63,"alternative-id":["S0168365919301890"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.03.029","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}